Delivery Order SPE2DB22D3501-SPE2DB24FWE05

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,059,641 units of the pharmaceutical product DEXTROAMP-AMPHET ER 20 MG CAP 100S. The $4,496.64 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to this major pharmaceutical distributor. The contract has a ceiling value of $4,496.64 and a completion date of July 3, 2024. Amerisourcebergen also holds a $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,692,876 units of DEXTROAMP-AMPHET ER 10 MG CAP 100S medication. The contract has a potential value of $3,410.36 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp also...
The U.S. Defense Logistics Agency (DLA) awarded a $1,157.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560909991 DEXTROAMP-AMPHETAMIN 10 MG TAB 100S to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $1,115.28, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a potential value of up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,025.98 Firm Fixed Price Delivery Order is for the supply of 4567684725 DEXTROAMP-AMPHET ER 20 MG CAP 100S, a prescription medication. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide 4563731880 - DEXTROAMP-AMPHET ER 20 MG CAP 100S. The $5,933.88 order has a completion date of February 22, 2024 and was awarded on February 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical worth up to...
The U.S. Defense Logistics Agency (DLA) awarded a $7,022.60 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide pharmaceutical products and medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.95 firm-fixed-price delivery order is for the supply of DEXTROAMP-AMPHET ER 25 MG CAP 100S, a prescription medication, with a period of performance through June 9, 2025. The contract is not set aside and allows for open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $1,509.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, with a performance period through April 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,972.03 firm fixed-price delivery order is for the supply of 4568346012 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, with an ultimate completion date of May 27, 2025. The contract is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWE05
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $11,351.76 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4565070301 - DEXTROAMP-AMPHET ER 10 MG CAP 100S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen, a major pharmaceutical distribution company, has significant expertise in fulfilling government contracts for critical medical commodities. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/2/24, 10:22 AM